Results 151 to 160 of about 43,410 (236)

Who Invented the VLP Cervical Cancer Vaccines? [PDF]

JNCI: Journal of the National Cancer Institute, 2006
openaire   +2 more sources

Virus Biomimetic-Delivery Systems for the Production of Vaccines. [PDF]

Biomimetics (Basel)
Barbinta-Patrascu ME, Negut I, Bita B.
europepmc   +1 more source

Expanding the power of VLPs [PDF]

Biotechnology and Bioengineering, 2014
openaire   +1 more source

Protocol for non-invasive delivery of CRISPR RNPs via virus-like particles for mouse model generation. [PDF]

STAR Protoc
Yoon DE, Yang J, Jeong TY, Park J, Lee H, Seong JK, Kim K.   +6 more
europepmc   +1 more source

The Disruption of the HIV-1 Gag Start Codon via Editing Using MmCas12m-Dual Base Editor-Loaded Virus-like Particles. [PDF]

Curr Issues Mol Biol
Aliev T, Imatdinov A, Prudnikova E, Taranov O, Emtsova K, Imatdinov I, Agafonov A.   +6 more
europepmc   +1 more source

VLP-based indirect ELISA enables reliable sero-diagnosis and epidemiological monitoring of duck circovirus. [PDF]

Front Vet Sci
Qiu S, Guo F, Zhao L, Zhong Z, Wang Y.
europepmc   +1 more source

Coxsackie B1 virus-like particle that lacks VP4 protein demonstrates improved vaccine scalability, stability and immunogenicity. [PDF]

J Biomed Sci
Soppela S, Kyröläinen HM, Levanova A, Nekoua MP, González-Rodríguez M, Lehto H, Ahmad KLL, Guryanov S, Hytönen VP, Laitinen OH, Junttila IS, Hober D, Butcher SJ, Hankaniemi MM.   +13 more
europepmc   +1 more source

Investigating antibody cross-reactivity and transmission dynamics of alphaviruses and flaviviruses using a multiplex serological assay. [PDF]

Nat Commun
Yman V, Rosado J, Ochida N, Garcia L, Gasasira MF, Baudemont G, Cramer E, Dupont-Rouzeyrol M, Huet K, Douine M, Sanna A, Lambert Y, Carrasco-Escobar G, Nolasco O, Gamboa D, Fall G, Ndiaye O, Faye O, Loucoubar C, Toure-Balde A, Niang M, Vigan-Womas I, Cauchemez S, White MT.   +23 more
europepmc   +1 more source

A cluster of acidic residues in the cytoplasmic domain of SARS-CoV-2 Spike is required for virion-incorporation and infectivity. [PDF]

PLoS One
Stoneham CA, Singh R, De Leon A, Tafelmeyer P, Acosta F, Fuori A, Anderson M, Ramirez PW, Schwartzer-Sperber HS, Pillai S, Lewinski MK, Guatelli J.   +11 more
europepmc   +1 more source

Identification of novel small chemical compounds that inhibit Ebola virus VP40-mediated virus-like particle production. [PDF]

Virus Res
Tsuruta T, Mizuta S, Izumisawa A, Yasuda J, Urata S.   +4 more
europepmc   +1 more source